To our knowledge, this is the first ovarian cancer study comprising the analysis of PIK3R1 mutations, copy number alterations, mRNA expression with respect to clinicopathological and molecular factors, and patients’ endpoints. Here, PIK3R1 is linked to ovarian cancer.